The first case of H5N1 bird flu was reported in Australia last week. Is the world prepared for what could lead to the next pandemic?
Clinical trials of an mRNA vaccine have begun, and researchers expect broadly positive outcomes in the fight against the widespread illness.
Influenza vaccines are recommended annually, but there’s now an increasing number of different vaccine types. Here’s what to know about this year’s shots.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
The Omicron strain is driving a rapid increase in China, and is quicker to transmit than other variants.
As the situation evolves, the World Health Organisation expects still more cases of monkeypox will be identified as surveillance expands in non-endemic countries.
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
When he volunteered to become one of the public faces of Victoria’s COVID-19 health response, Professor Allen Cheng’s life changed course dramatically – and accelerated.
Although it was a century ago, there are parallels between the Spanish Flu pandemic and COVID-19. What was it like on the frontline for our healthcare workers this time around – and what have we learnt as a society?
Two Monash students – and also firm friends – are on a mission to boost the uptake of the influenza vaccine.
COVID-19 has highlighted what's possible when the collective will exists to mobilise attention and healthcare resources – something the slow emergence of chronic disease could not.
Early analysis suggests Pfizer's COVID-19 vaccine has an efficacy of more than 90%, but more data is still needed.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
Most people diagnosed with COVID-19 can manage their illness at home, but some patients deteriorate after about five days. Fortunately, Australian doctors have up-to-the-minute treatment guidelines.
Many parents are unsure how to discuss the pandemic with their children, but there are ways to tackle the tricky questions.
How we responded to pandemics in the past can carry lessons for the current COVID-19 situation.
Forget the finger-pointing – public communications that promote collective action will make our pandemic-clouded lives a little easier.
Critically ill patients from intensive care units are part of a global trial testing a suite of flu and pneumonia drugs in a bid to combat COVID-19.
How prepared are we to give up some personal freedoms, and how do we allocate scarce resources? These are just some of the tough questions we face.
The adjuvanted flu vaccine is free for over-65s and offers better protection than the standard vaccine. Here's what the research says.
Two free flu vaccines will improve protection for older people, but like those already available, they're not perfect.
Dummy text
